Dr. Stuart Johnson, MD

NPI: 1184601452
Total Payments
$42,944
2023 Payments
$12,439
Companies
6
Transactions
49

Payment Breakdown by Category

Consulting$34,935 (81.3%)
Travel$4,774 (11.1%)
Other$1,840 (4.3%)
Food & Beverage$1,395 (3.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $34,935 12 81.3%
Travel and Lodging $4,774 16 11.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,840 1 4.3%
Food and Beverage $1,395 20 3.2%

Top Paying Companies

Company Total Records Latest Year
Ferring Pharmaceuticals Inc. $32,582 33 $0 (2023)
PFIZER INC. $6,476 12 $0 (2020)
Paratek Pharmaceuticals, Inc. $3,000 1 $0 (2022)
Valneva Austria GmbH $700.00 1 $0 (2017)
Genentech USA, Inc. $128.94 1 $0 (2018)
Merck Sharp & Dohme Corporation $57.49 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $12,439 15 Ferring Pharmaceuticals Inc. ($12,439)
2022 $7,862 4 Ferring Pharmaceuticals Inc. ($4,862)
2021 $9,200 3 Ferring Pharmaceuticals Inc. ($9,200)
2020 $160.07 3 PFIZER INC. ($148.98)
2019 $8,593 15 Ferring Pharmaceuticals Inc. ($6,070)
2018 $1,129 2 PFIZER INC. ($1,000)
2017 $3,561 7 PFIZER INC. ($2,804)

All Payment Transactions

49 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/19/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Consulting Fee Cash or cash equivalent $7,612.50 General
Category: GASTROENTEROLOGY
04/29/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $81.19 General
Category: GASTROENTEROLOGY
04/29/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $61.00 General
Category: GASTROENTEROLOGY
04/29/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $47.36 General
Category: GASTROENTEROLOGY
04/29/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $47.36 General
Category: GASTROENTEROLOGY
04/29/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Travel and Lodging In-kind items and services $40.35 General
Category: GASTROENTEROLOGY
04/29/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $6.59 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Travel and Lodging In-kind items and services $1,056.70 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Travel and Lodging In-kind items and services $410.55 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $175.91 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Travel and Lodging In-kind items and services $123.00 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $63.49 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Travel and Lodging In-kind items and services $48.99 General
Category: GASTROENTEROLOGY
04/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $38.90 General
Category: GASTROENTEROLOGY
04/25/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Consulting Fee Cash or cash equivalent $2,625.00 General
Category: GASTROENTEROLOGY
11/01/2022 Ferring Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,390.00 General
10/20/2022 Ferring Pharmaceuticals Inc. Food and Beverage In-kind items and services $82.06 General
08/16/2022 Ferring Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,390.00 General
04/01/2022 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: ANTIBIOTIC
11/03/2021 Ferring Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $4,600.00 General
02/09/2021 Ferring Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,760.00 General
02/03/2021 Ferring Pharmaceuticals Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,840.00 General
02/20/2020 Ferring Pharmaceuticals Inc. Food and Beverage In-kind items and services $11.09 General
02/12/2020 PFIZER INC. Travel and Lodging In-kind items and services $74.49 General
01/23/2020 PFIZER INC. Travel and Lodging In-kind items and services $74.49 General

About Dr. Stuart Johnson, MD

Dr. Stuart Johnson, MD is a Infectious Disease healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184601452.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Johnson, MD has received a total of $42,944 in payments from pharmaceutical and medical device companies, with $12,439 received in 2023. These payments were reported across 49 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($34,935).

Practice Information

  • Specialty Infectious Disease
  • Location Maywood, IL
  • Active Since 12/28/2005
  • Last Updated 07/08/2007
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1184601452

Products in Payments

  • REBYOTA (Biological) $12,439
  • NUZYRA (Drug) $3,000
  • TECENTRIQ (Biological) $128.94
  • DIFICID (Drug) $57.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Maywood